+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fludarabine"

Follicular Lymphoma Treatment Market Report 2025 - Product Thumbnail Image

Follicular Lymphoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Waldenstrom's Macroglobulinemia - Pipeline Insight, 2024 - Product Thumbnail Image

Waldenstrom's Macroglobulinemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Fludarabine is a chemotherapy drug used to treat chronic lymphocytic leukemia (CLL). It is a purine analog, which works by interfering with the growth of cancer cells. It is usually given in combination with other drugs, such as cyclophosphamide and rituximab. Fludarabine is also used to treat other types of leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is also used to treat some types of non-Hodgkin's lymphoma. Fludarabine is generally well-tolerated, but can cause side effects such as nausea, vomiting, diarrhea, and hair loss. It can also cause low white blood cell counts, which can increase the risk of infection. Fludarabine is available in both generic and brand-name formulations. Some of the companies that produce fludarabine include Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more